Patent · US Active

Antibodies recognizing tau

US11584791B2 · kind B2 · utility

0Cited by
64References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 4, 2020
Grant dateFeb 21, 2023
Priority date—
Expiry dateMar 6, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.